Overview

Trichomylin® Safety, Tolerability, and Pharmacokinetics in Healthy Adults and First in Human Osteoarthritis Pain Evaluation

Status:
Recruiting

Trial end date:
2022-02-10

Target enrollment:

Participant gender:

Summary

This is a first in human, randomized, double blind, SAD (with food effect) followed by a MAD study of Trichomylin® conducted in healthy adult participants.

Phase:

Phase 1

Details

Lead Sponsor:

ZYUS Life Sciences Inc.

Collaborators:

Novotech (Australia) Pty Limited
ZYUS Life Sciences Australia Pty Ltd